Mark Cuban's drug company creates pharmacy network to challenge PBMs; FDA says some can get a spring Covid booster

Taking stock of the drug industry, from the lab to the medicine chest

April 18, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Kris Connor/Getty Images for A+E Networks STAT+ | Mark Cuban's drug company creates a pharmacy network to challenge PBMs "Cuban has taken his first step into a larger pharmacy world," said Antonio Ciaccia, who heads 3 Axis Advisors. By Ed Silverman STAT+ | GSK to buy Bellus Health for $2 billion, gaining chronic cough drug With the Bellus Health acquisition, GSK will get the experimental drug camlipixant, which is in a Phase 3 trial for refractory chronic cough. By Andrew Joseph FDA says older adults and the immunocompromised may get a spring booster dose of Covid vaccine The immunocompromised may also receive an additional dose of Covid-19 vaccine, the FDA said in a statement. By Helen Branswell APStock STAT+ | Most large U.S. funders of clinical research have poor transparency policies, analysis finds Most organizations failed to adopt best disclosure practices recommended by the World Health Organization, the analysis found. By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser